ShareTweetShareBucillamine Just Got Cleared for Phase 3 Trials of COVID-19 On Friday, July 31, 2020 Revive Therapeutics (CSE: RVV) (OTC: … Continue reading Three Things to Know About ‘Phase 3 COVID Player’: Revive Therapeutics